You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Details for Patent: 8,003,679

✉ Email this page to a colleague

« Back to Dashboard

Title:	Use of inhibitors of the renin-angiotensin system
Abstract:	Inhibitors of the rennin-angiotensin system are useful for the treatment or prevention of conditions associated with hypoxia, such as stroke.
Inventor(s):	Montgomery; Hugh Edward (London, GB), Martin; John Francis (London, GB), Erusalimsky; Jorge Daniel (London, GB)
Assignee:	ArkTherapeutics Group, plc (London, GB)
Filing Date:	May 25, 2006
Application Number:	11/441,648
Claims:	1. A method for the treatment or prevention of stroke, wherein said method comprises administering, to a human patient diagnosed as in need of such treatment or prevention of stroke, in an amount effective for the treatment or prevention of stroke, telmisartan, wherein said patient is a normotensive or hypotensive human patient. 2. The method of claim 1, said wherein said patient is a male.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.